Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Context Therapeutics
Recent news which mentions Context Therapeutics
Context Therapeutics CEO Marty Lehr notes progress towards the clinic with CTIM-76 in 2Q update
August 10, 2023
Tickers
CNTX
Tags
Context Therapeutics
XNAS:CNTX
From
TheNewswire.com - RSS (Media)
Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update
June 13, 2023
Tags
Context Therapeutics
XNAS:CNTX
From
TheNewswire.com - RSS (Media)
ASCO 2023 – Claudin 6 Makes A Splash In Ovarian Cancer
June 08, 2023
Tickers
AMGN
BNTX
CNTX
Tags
CNTX
General
BNTX
From
Benzinga
Context Therapeutics CTIM-76 bispecific antibody preclinical data presented at AACR Annual Meeting
April 24, 2023
Tags
Context Therapeutics
XNAS:CNTX
From
TheNewswire.com - RSS (Media)
Significant Unmet Need In Solid Tumors Reported, And How Context Therapeutics (NASDAQ: CNTX) Plans To Make A Difference
April 14, 2023
Tickers
CNTX
Tags
General
CNTX
Benzinga
From
Benzinga
Lab Notes: Center for Breakthrough Medicines expands offerings; Researchers identify key 'gene signature'
February 10, 2023
Tickers
INNO
Tags
Inno
Context Therapeutics
Biotech
From
Business Journals
Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapy
December 09, 2022
Tickers
INNO
Tags
Gerri Henwood
Incyte Corp/
John H/ Johnson
From
Business Journals
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
December 06, 2022
Tags
XNAS:CNTX
Context Therapeutics
From
TheNewswire.com - RSS (Media)
Context Therapeutics Partners With Integral Molecular To Develop An Emerging Cancer Drug
November 10, 2022
Tickers
CNTX
Tags
Benzinga
CNTX
General
From
Benzinga
New Ammo In The Battle Against Cancer – Context Therapeutics Sees Promising Results For Several Novel Drugs
August 17, 2022
Tickers
CNTX
Tags
Benzinga
Penny Stocks
Market News
From
Benzinga
Lab Notes: Wistar Institute gets $5M NCI grant extension; Aclaris expands management team
August 05, 2022
Tickers
INNO
Tags
Ted White
Douglas Manion
Trevena Inc/
From
Business Journals
Lab Notes: Oncora Medical doubles its client base; Context Therapeutics posts promising cancer drug data
April 15, 2022
Tickers
INNO
Tags
Chris Garabedian
Insurance
Evan Dick
From
Business Journals
What About Women? This Company Targets Female-Focused Cancers
January 31, 2022
Tickers
CNTX
Tags
Partner Content
Market News
Context Therapeutics
From
Benzinga
Context Therapeutics raises $31M in fresh funding from stock sale
December 07, 2021
Tags
Martin Lehr
Pharmaceuticals
Felix Kim
From
Business Journals
Lab Notes: CHOP-based brain tumor network gets NIH boost; Integral Molecular inks deal with Astrazeneca
November 05, 2021
Tickers
INNO
Tags
Insurance
Adam Resnick
Benjamin Doranz
From
Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
October 29, 2021
Tickers
INNO
Tags
Mark Foster
Inovio Pharmaceuticals Inc/
Windtree Therapeutics Inc/
From
Business Journals
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.